Pfizer Stock In The News

PFE -  USA Stock  

USD 51.34  0.67  1.32%

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Pfizer and other traded companies coverage. We help investors stay connected with Pfizer headlines for the 18th of May 2022 to make an informed investment decision based on correlating the impacts of news items on Pfizer Stock performance. Please note that trading solely based on the Pfizer Inc hype is not for everyone as timely availability and quick action are needed to avoid losses.
  
Refresh
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Pfizer headlines in addition to utilizing other, more conventional financial analysis modules. Please check Pfizer Backtesting and Pfizer Hype Analysis.
Pfizer's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Pfizer Inc investors visualize upcoming and past events in order to time the market based on Pfizer Inc noise-free hype analysis.
Pfizer stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Pfizer earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
There is far too much social signal, news, headlines, and media speculation about Pfizer that is available to investors today. That information is available publicly through Pfizer media outlets and privately through word of mouth or via Pfizer internal channels. However, regardless of the origin, that massive amount of Pfizer data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Pfizer news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Pfizer relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Pfizer's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Pfizer alpha.

Pfizer Largest EPS Surprises

Earnings surprises can significantly impact Pfizer's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1999-07-19
1999-06-300.170.190.0211 
1998-10-13
1998-09-300.190.17-0.0210 
1998-07-09
1998-06-300.150.170.0213 
2000-04-18
2000-03-310.250.280.0312 
2009-04-28
2009-03-310.490.540.0510 
2008-01-23
2007-12-310.470.520.0510 
View All Earnings Estimates

Pfizer Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Pfizer Inc Stock. The global stock market is bearish. About 60% of major world exchanges and indexes are down. See today's market update for more information.
fool News
17th of May 2022
Pfizers Setbacks With Paxlovid Are Mounting -- Should Investors Be Concerned - The Motley ...
at www.fool.com 
Macroaxis News
12th of May 2022
Discretionary transaction by Mikael Dolsten of 15167 shares of Pfizer subject to Rule 16b-...
at MacroaxisInsider 
news
9th of May 2022
Pfizer exotic insider transaction detected
at www.business2community.com 
nasdaq News
2nd of May 2022
Acquisition by Jennifer Damico of tradable shares of Pfizer subject to Rule 16b-3
at www.nasdaq.com 
news
27th of April 2022
The 5 Best Healthcare Stocks To Own Right Now - Schaeffers Research
at www.schaeffersresearch.com 
seekingalpha News
21st of April 2022
Pfizer A Portfolio Prescription For Inflation Investing - Seeking Alpha
at seekingalpha.com 
Marketbeat News
18th of April 2022
Pfizer Upgraded to Strong-Buy at StockNews.com - MarketBeat
at www.marketbeat.com 
Thestreet News
12th of April 2022
Veru Stock Soars, Retreats After Impressive Data From Covid Treatment Trial - TheStreet
at www.thestreet.com 
news
7th of April 2022
Pfizer to Acquire ReViral and Its Respiratory Syncytial Virus Therapeutic Candidates - Pfi...
at www.pfizer.com 
nasdaq News
1st of April 2022
Acquisition by Pao William of 115897 shares of Pfizer subject to Rule 16b-3
at www.nasdaq.com 
seekingalpha News
8th of March 2022
Arena Pharma ticks higher on Nasdaq delisting notice for Pfizer deal - Seeking Alpha
at seekingalpha.com 

Pfizer Investors Sentiment

The influence of Pfizer's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Pfizer. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock markets does not have a solid backing from leading economists and market statisticians.

Pfizer Implied Volatility

    
  44.35  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Pfizer in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Pfizer's short interest history, or implied volatility extrapolated from Pfizer options trading.

Current Sentiment - PFE

Pfizer Inc Investor Sentiment

Predominant part of Macroaxis users are at this time bullish on Pfizer Inc. What is your perspective on investing in Pfizer Inc? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Currently Active Assets on Macroaxis

Please check Pfizer Backtesting and Pfizer Hype Analysis. Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Bond Directory module to find actively traded corporate debentures issued by US companies.

Complementary Tools for Pfizer Stock analysis

When running Pfizer Inc price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Go
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine Pfizer value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.